Citations

Clear

1575 citation(s) found for "Im, Gene".

Engineered CRISPR Systems for Next Generation Gene Therapies
Pineda, Michael , Moghadam, Farzaneh , Ebrahimkhani, Mo R. , Kiani, Samira , Pineda, Michael

Mayo Clinic

ACS Synthetic Biology | May 30, 2017 | Volume: 6 | Issue: 9 | Pages: 1614-1626

10.1021/acssynbio.7b00011 | PMID 28558198 Get It

Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV
Velázquez-Salinas, Lauro , Naik, Shruthi , Pauszek, Steven J. , Peng, Kah-Whye , Russell, Stephen J. , Rodrı́guez, Luis L. , Russell, Stephen J

Mayo Clinic

Human Gene Therapy Clinical Development | May 18, 2017 | Volume: 28 | Issue: 2 | Pages: 108-115

10.1089/humc.2017.015 | PMID 28514874 Get It

Intranuclear and higher‐order chromatin organization of the major histone gene cluster in breast cancer
Fritz, Andrew J. , Ghule, Prachi N. , Tye, Coralee E. , Page, Natalie A., Hong, Deli , Shirley, David J. , Weinheimer, Adam, Gerrard, Diana L., Frietze, Seth , Wijnen, André J. van , Zaidi, Sayyed K. , Imbalzano, Anthony N. , Lian, Jane B. , Stein, Janet L. , van Wijnen, Andre J, Boyd, Joseph R. , Barutcu, A. Rasim , Stein, Gary S. , van Wijnen, Andre J

Mayo Clinic

Journal of Cellular Physiology | May 15, 2017 | Volume: 233 | Issue: 2 | Pages: 1278-1290

10.1002/jcp.25996 | PMID 28504305 Get It

Alterations in nuclear morphology are common in cancer progression. However, the degree to which gross morphological abnormalities translate into compromised higher‐order chromatin organization is poorly understood. To explore the functional links between gene expression and chromatin structure in breast cancer, we performed RNA‐seq gene expression analysis on the basal breast cancer progression model based on human MCF10A cells. Positional gene enrichment identified the major histone gene cluster at chromosome 6p22 as one of the most significantly upregulated (and not amplified) clusters of genes from the normal‐like MCF10A to premalignant MCF10AT1 and metastatic MCF10CA1a cells. This cluster is subdivided into three sub‐clusters of histone genes that are organized into hierarchical topologically associating domains (TADs). Interestingly, the sub‐clusters of histone genes are located at TAD boundaries and interact more frequently with each other than the regions in‐between them, suggesting that the histone sub‐clusters form an active chromatin hub. The anchor sites of loops within this hub are occupied by CTCF, a known chromatin organizer. These histone genes are transcribed and processed at a specific sub‐nuclear microenvironment termed the major histone locus body (HLB). While the overall chromatin structure of the major HLB is maintained across breast cancer progression, we detected alterations in its structure that may relate to gene expression. Importantly, breast tumor specimens also exhibit a coordinate pattern of upregulation across the major histone gene cluster. Our results provide a novel insight into the connection between the higher‐order chromatin organization of the major HLB and its regulation during breast cancer progression.
Exclusion of Eligible Indeterminate Thyroid Nodules in Estimates of Negative Predictive Value for the Gene Expression Classifier
Rahilly‐Tierney, Catherine , Gharib, Hossein, Duh, Quan‐Yang

Mayo Clinic

JAMA Otolaryngology–Head & Neck Surgery | April 27, 2017 | Volume: 143 | Issue: 7 | Pages: 737

10.1001/jamaoto.2017.0249 | PMID 28448653 Get It

Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair
Nargesi, Arash Aghajani , Lerman, Lilach O. , Eirin, Alfonso , Eirin, Alfonso

Mayo Clinic

Current Gene Therapy | April 13, 2017 | Volume: 17 | Issue: 1 | Pages: No page available

10.2174/1566523217666170412110724 | PMID 28403795 Get It

Intra-Familial Clinical Heterogeneity due to FTLD-U with TDP-43 Proteinopathy Caused by a Novel Deletion in Progranulin Gene (PGRN)
Gabryelewicz, Tomasz, Berdyński, Mariusz , Bilbao, Juan M., George‐Hyslop, Peter St , Barczak, Anna , Barcikowska, Maria , Black, Sandra E. , Żekanowski, Cezary , Masellis, Mario , Rogaeva, Ekaterina A. , Czyźewski, K , Wszołek, Zbigniew K.

Mayo Clinic

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 22 | Issue: 4 | Pages: 1123-1133

10.3233/jad-2010-101413 | PMID 20930269 Get It

Reduced Posterior Cingulate Mitochondrial Activity in Expired Young Adult Carriers of the APOE ε4 Allele, the Major Late-Onset Alzheimer's Susceptibility Gene
Valla, Jon, Yaari, R. , Wolf, Andrew B. , Kusne, Yael , Beach, Thomas G. , Roher, Alex E., Corneveaux, Jason J., Huentelman, Matthew J. , Caselli, Richard J. , Reiman, Eric M.

Mayo Clinic

Journal of Alzheimer's Disease | April 5, 2017 | Volume: 22 | Issue: 1 | Pages: 307-313

10.3233/jad-2010-100129 | PMID 20847408 Get It

KS1 (KRAB suppressor of transformation 1) and BMP3b (bone morphogenetic protein 3b) gene promoter hypermethylation is a common epigenetic event in breast cancer
Molina, Julian R. , Alzein, N. J., Lingle, Wilma L., Fernandez-Zampico, M., Hartmann, Lynn C. , Urrutia, Raúl

Mayo Clinic

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 9608-9608

10.1200/jco.2004.22.90140.9608 Get It

Long-term aspirin use and intratumoral gene expression in prostate cancer.
Downer, Mary K. , Mucci, Lorelei A. , Stopsack, Konrad H. , Ebot, Ericka M. , Rider, Jennifer R.

Mayo Clinic

Journal of Clinical Oncology | March 29, 2017 | Volume: 35 | Issue: 6_suppl | Pages: 106-106

10.1200/jco.2017.35.6_suppl.106 Get It

106 Background: Pharmacoepidemiologic studies suggest prognostic benefits of aspirin in prostate cancer. We hypothesized that prostate cancer tissue from regular aspirin users at cancer diagnosis compared to nonusers is characterized by specific transcriptional changes. Methods: We analyzed tumor whole-transcriptome data from men diagnosed with prostate cancer during prospective follow up of the Physicians Health Study 1 (PHS1, n1 = 150), initially a randomized-controlled trial of aspirin for prevention of cardiovascular disease and cancer. We compared the expression of putative aspirin target genes ( PTGS2, CTNNB1, MYC, AXIN2, PTGER3) between regular aspirin users ( ≥ 3 x 324 mg/week) and non-users at cancer diagnosis. We used Gene Set Enrichment Analysis to identify Gene Ontology biological process gene sets (total, 3609) associated with aspirin use. Leading edge genes of ≥ 3 functionally related gene sets were summarized in a meta-gene score. Results were validated among prostate cancer patients from the Health-Professionals Follow-up Study (HPFS, n2 = 254; aspirin use, ≥ 2 x/week). Results: Regular aspirin use was common (65% in PHS1; 45% in HPFS) and not associated with age, stage, and Gleason grade. In PHS1, none of the predefined genes were associated with aspirin use (all p > 0.05). 26 gene sets were downregulated in aspirin users at a false discovery rate (FDR) < 0.25 (9 at FDR < 0.05). 11 gene sets were clustered functionally around ribosome function and protein translation. A “ribosome” score of 96 genes was higher in aspirin users compared to nonusers (difference, 35.5 standard deviations [SD]; p = 0.0001). There was no dose-dependency for cumulative duration of aspirin use before cancer diagnosis ( ptrend = 0.17) or time since stopping use among non-users at diagnosis ( p = 0.32). In HPFS, neither the pre-defined target genes (all p > 0.18) nor the score were associated with aspirin use (difference, –9.8 SD; p = 0.18). Conclusions: Although RNA acetylation and resulting intratumoral gene expression changes due to aspirin use may be biologically plausible, we were unable to corroborate this association in two-long term prospective studies. Short-term trials might assess if aspirin has direct effects on tumor gene expression.
Clinical, histopathological, and molecular features of mucosa-associated lymphoid tissue (MALT) lymphoma carrying the t(X;14) (p11;q32)/GPR34-immunoglobulin heavy chain gene
Akasaka, Takashi , Lee, Yin-Fai, Novak, Anne J. , Honjo, Gen, Takeoka, Kayo, Maekawa, Fumiyo, Fukutsuka, Katsuhiro, Hayashida, Masahiko, Ohno, Hitoshi

Mayo Clinic

Leukemia & Lymphoma | March 24, 2017 | Volume: 58 | Issue: 9 | Pages: 2247-2250

10.1080/10428194.2017.1289525 | PMID 28278700 Get It